Addex Therapeutics, during its Q3 2023 earnings call, provided updates on its financial results and progress in various drug development programs. The company highlighted achievements such...
Addex Therapeutics (Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced it had received written...
Addex Therapeutics, a biopharmaceutical company known for its allosteric modulation-based drug development, has regained compliance with NASDAQ's $1 per ADS minimum bid price requirement....
Addex Therapeutics (Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it plans to change the...
Investing.com - Addex Therapeutics (NASDAQ: ADXN) reported second quarter EPS of $-0.0400, in line with the analyst estimate of $-0.0400. Revenue for the quarter came in at $720.93K versus...
Investing.com - Addex Therapeutics (NASDAQ: ADXN) reported first quarter EPS of $-0.27, $0.22 worse than the analyst estimate of $-0.05. Revenue for the quarter came in at $564.55K versus...
Addex Therapeutics (Nasdaq: ADXN) today announced that the ADX71149 (JNJ-40411813) Phase 2 epilepsy clinical study has been recommended to continue by an Independent Interim Review...
Addex Therapeutics Ltd (Nasdaq: ADXN) today announced that it has entered into a definitive agreement with a leading institutional healthcare investor (the “Investor”) to sell 7,999,998...
Investing.com - Addex Therapeutics reported on Friday third quarter {{erl-1163716||earnings that matched analysts' forecasts and revenue that fell short of expectations. Addex Therapeutics...
Addex Therapeutics Ltd (ADXN) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $420 thousand versus the consensus estimate of...
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Telecoms, Technology and Consumer Services sectors propelled shares higher while losses in the Oil & Gas,...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Oil & Gas and Consumer Goods sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Consumer Services, Technology and Financials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Technology, Consumer Services and Consumer Goods sectors propelled shares lower. At the close in NYSE,...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Oil & Gas, Industrials and Basic Materials sectors propelled shares higher while losses in the Healthcare,...
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Utilities, Telecoms and Financials sectors propelled shares higher while losses in the Technology, Consumer...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
